Lupus Ventures

Lupus Ventures operates as a philanthropic venture fund, focused solely on systemic lupus erythematosus (SLE) and related autoimmune diseases. It invests in and supports the development of novel treatments and diagnostic tools, aiming to accelerate their journey from research to clinical availability. The fund seeks to enhance care standards for lupus patients through targeted investment.

The Lupus Research Alliance established Lupus Ventures to address a significant funding void within lupus research and development. Nishant Rastogi serves as its inaugural Managing Director. The fund was conceived from the imperative to expedite scientific breakthroughs, bringing effective solutions rapidly to individuals afflicted with this complex and often debilitating condition.

Lupus Ventures' work ultimately benefits millions living with lupus globally, providing improved therapeutic options and advanced diagnostics. Its vision is to fundamentally transform lupus management, driving progress that yields superior patient outcomes and an enhanced quality of life for those impacted by the chronic autoimmune disease.